Article
Exploring effective biomarkers and potential immune related gene in small cell lung cancer
31 Mar 2024
Abstract excerpt
Small cell lung cancer (SCLC) is well known as a highly malignant neuroendocrine tumor. Immunotherapy combined with chemotherapy has become a standard treatment for extensive SCLC. However, since most patients quickly develop resistance and relapse, finding new therapeutic targets for SCLC is important. We obtained four microarray datasets from the Gene Expression Omnibus database and screened differentially...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
